Quiz
Quiz: Safety and Efficacy of Belantamab Mafodotin for Relapsed/Refractory MM
04/06/2022
Current Issue
August 2025
Volume 11
Issue 4
JCP Clinical Pathways Categories
Subscribe
Journal of Clinical Pathways Newsletter